Insulin-producing cell clusters derived from human gingival mesenchymal stem cells as a model for diabetes research.
Diabetes mellitus
Differentiation
Gingiva
Insulin producing cell clusters
Mesenchymal stem cells
Journal
Molecular biology reports
ISSN: 1573-4978
Titre abrégé: Mol Biol Rep
Pays: Netherlands
ID NLM: 0403234
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
20
06
2022
accepted:
04
10
2022
pubmed:
23
10
2022
medline:
3
12
2022
entrez:
22
10
2022
Statut:
ppublish
Résumé
The human gingiva-derived mesenchymal stem cells (hGMSCs) possess a great potential to develop the cell-based therapy for diabetes due to its unscarred healing capacity and reparative potential. In this current study, we isolated, cultured and characterised the GMSCs and explored their potential to differentiate into Insulin Producing Cell Clusters (IPCCs). The cells derived from gingival tissues exhibited fibroblast-like morphology. The flow cytometric analysis revealed positive expression of CD73(97.43%), CD90(95.05%), and CD105(93.17%) and negative expression of CD34(0.05%), CD45(0.09%), and HLA-DR (0.025) surface markers. We then converted this adherent fibroblast-like GMSCs into floating IPCCs using a sequential three-step protocol containing a different combination of differentiating agents. Initially, the presence of insulin in IPCCs was confirmed by dithizone staining. Glucose-stimulated insulin secretion (GSIS) assay confirmed that IPCCs secrete insulin in response to glucose. Generated IPCCs express pancreatic markers such as insulin, pdx1, glucagon, GLUT4 and GLUT2 as evidenced by RT-PCR analysis. Our results unequivocally showed that IPCCs can be generated from gingiva which is a potential source of postnatal MSCs. Our results offer the IPCCs generated from hGMSCs a platform for screening anti-diabetic drugs and a new autologous source of tissue for islet transplantation for the treatment of diabetes. Our results unequivocally demonstrate for the first time that hGMSCs can be used as an attractive non-invasive tissue source for generating IPCCs, which can be employed in diabetes research for screening antidiabetic agents and also for transplantation in type 1 diabetic patients as autologous source without the need of immunosuppression.
Sections du résumé
BACKGROUND
BACKGROUND
The human gingiva-derived mesenchymal stem cells (hGMSCs) possess a great potential to develop the cell-based therapy for diabetes due to its unscarred healing capacity and reparative potential. In this current study, we isolated, cultured and characterised the GMSCs and explored their potential to differentiate into Insulin Producing Cell Clusters (IPCCs).
METHODS
METHODS
The cells derived from gingival tissues exhibited fibroblast-like morphology. The flow cytometric analysis revealed positive expression of CD73(97.43%), CD90(95.05%), and CD105(93.17%) and negative expression of CD34(0.05%), CD45(0.09%), and HLA-DR (0.025) surface markers. We then converted this adherent fibroblast-like GMSCs into floating IPCCs using a sequential three-step protocol containing a different combination of differentiating agents. Initially, the presence of insulin in IPCCs was confirmed by dithizone staining. Glucose-stimulated insulin secretion (GSIS) assay confirmed that IPCCs secrete insulin in response to glucose.
RESULTS
RESULTS
Generated IPCCs express pancreatic markers such as insulin, pdx1, glucagon, GLUT4 and GLUT2 as evidenced by RT-PCR analysis. Our results unequivocally showed that IPCCs can be generated from gingiva which is a potential source of postnatal MSCs. Our results offer the IPCCs generated from hGMSCs a platform for screening anti-diabetic drugs and a new autologous source of tissue for islet transplantation for the treatment of diabetes.
CONCLUSIONS
CONCLUSIONS
Our results unequivocally demonstrate for the first time that hGMSCs can be used as an attractive non-invasive tissue source for generating IPCCs, which can be employed in diabetes research for screening antidiabetic agents and also for transplantation in type 1 diabetic patients as autologous source without the need of immunosuppression.
Identifiants
pubmed: 36271309
doi: 10.1007/s11033-022-08008-6
pii: 10.1007/s11033-022-08008-6
doi:
Substances chimiques
Insulin
0
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
11973-11982Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.
Références
Tabish SA (2007) Is diabetes becoming the biggest epidemic of the twenty-first century? Int J Health Sci (Qassim) 1:5–8
Meloche RM (2007) Transplantation for the treatment of type 1 diabetes. World J Gastroenterol 13:6347–6355. https://doi.org/10.3748/wjg.v13.i47.6347
doi: 10.3748/wjg.v13.i47.6347
pubmed: 18081223
pmcid: 4205453
Solis MA, Moreno Velásquez I, Correa R, Huang LLH (2019) Stem cells as a potential therapy for diabetes mellitus: a call-to-action in Latin America. Diabetol Metab Syndr 11:1–13. https://doi.org/10.1186/s13098-019-0415-0
doi: 10.1186/s13098-019-0415-0
Patil VR, Kharat AH, Kulkarni DG et al (2018) Long term explant culture for harvesting homogeneous population of human dental pulp stem cells. Cell Biol Int 42:1602–1610. https://doi.org/10.1002/cbin.11065
doi: 10.1002/cbin.11065
pubmed: 30353965
Debeljak-Martacic J, Francuski J, Luzajic T et al (2014) Characterization of deciduous teeth stem cells isolated from crown dental pulp. Vojnosanit Pregl 71:735–741. https://doi.org/10.2298/VSP1408735D
doi: 10.2298/VSP1408735D
Abedian Z, Jenabian N, Moghadamnia AA et al (2020) A comparative study on immunophenotypic characterization and osteogenic differentiation of human mesenchymal stromal cells derived from periodontal ligament and gingiva. J Periodontol. https://doi.org/10.1002/jper.19-0535
doi: 10.1002/jper.19-0535
pubmed: 31960428
Yu S, Li J, Zhao Y et al (2020) Comparative secretome analysis of mesenchymal stem cells from dental apical papilla and bone marrow during early odonto/osteogenic differentiation: potential role of transforming growth factor-β 2. Front Physiol 11:1–14. https://doi.org/10.3389/fphys.2020.00041
doi: 10.3389/fphys.2020.00041
Zhou T, Pan J, Wu P et al (2019) Dental follicle cells: roles in development and beyond. Stem Cells Int. https://doi.org/10.1155/2019/9159605
doi: 10.1155/2019/9159605
pubmed: 31949442
pmcid: 6948329
Venkatesh D, Kumar KPM, Alur JB (2020) Gingival mesenchymal stem cells. J Oral Maxillofac Pathol 21:296–298. https://doi.org/10.4103/jomfp.JOMFP
doi: 10.4103/jomfp.JOMFP
Zheng C, Chen J, Liu S, Jin Y (2019) Stem cell-based bone and dental regeneration: a view of microenvironmental modulation. Int J Oral Sci. https://doi.org/10.1038/s41368-019-0060-3
doi: 10.1038/s41368-019-0060-3
pubmed: 31451690
pmcid: 6802676
Somani R, Jaidka S, Bajaj N, Arora S (2017) Miracle cells for natural dentistry—a review. J Oral Biol Craniofacial Res 7:49–53. https://doi.org/10.1016/j.jobcr.2015.11.007
doi: 10.1016/j.jobcr.2015.11.007
Sun Q, Nakata H, Yamamoto M et al (2019) Comparison of gingiva-derived and bone marrow mesenchymal stem cells for osteogenesis. J Cell Mol Med 23:7592–7601. https://doi.org/10.1111/jcmm.14632
doi: 10.1111/jcmm.14632
pubmed: 31657140
pmcid: 6815943
Zhang W, Zhou L, Dang J et al (2017) Human gingiva-derived mesenchymal stem cells ameliorate streptozoticin-induced T1DM in mice via suppression of T effector cells and up-regulating treg subsets. Sci Rep 7:1–12. https://doi.org/10.1038/s41598-017-14979-5
doi: 10.1038/s41598-017-14979-5
Govindasamy V, Ronald VS, Abdullah AN et al (2011) Differentiation of dental pulp stem cells into islet-like aggregates. J Dent Res 90:646–652. https://doi.org/10.1177/0022034510396879
doi: 10.1177/0022034510396879
pubmed: 21335539
Bhonde RR (2011) Differentiation of dental pulp stem cells into islet-like aggregates. J Dent Res 90:646–652. https://doi.org/10.1177/0022034510396879
doi: 10.1177/0022034510396879
pubmed: 21335539
Chandravanshi B, Bhonde RR (2017) Shielding engineered islets with mesenchymal stem cells enhance survival under hypoxia. J Cell Biochem 118:2672–2683. https://doi.org/10.1002/jcb.25885
doi: 10.1002/jcb.25885
pubmed: 28098405
Journal AI, Lan K, Wang C et al (2018) Islet-like clusters derived from skeletal muscle-derived stem/progenitor cells for autologous transplantation to control type 1 diabetes in mice. Artif Cells Nanomed Biotechnol. https://doi.org/10.1080/21691401.2018.1492421
doi: 10.1080/21691401.2018.1492421
Kadam S, Muthyala S, Nair P, Bhonde R (2010) Human placenta-derived mesenchymal stem cells and islet-like cell clusters generated from these cells as novel sources for stem cell therapy in diabetes. Rev Diabet Stud 7:168–182. https://doi.org/10.1900/RDS.2010.7.168
doi: 10.1900/RDS.2010.7.168
pubmed: 21060975
pmcid: 2989789
Kharat A, Chandravanshi B, Gadre S et al (2019) IGF-1 and somatocrinin trigger islet differentiation in human amniotic membrane derived mesenchymal stem cells. Life Sci 216:287–294. https://doi.org/10.1016/j.lfs.2018.11.028
doi: 10.1016/j.lfs.2018.11.028
pubmed: 30444986
Mitrano TI, Grob MS, Carrión F et al (2010) Culture and characterization of mesenchymal stem cells from human gingival tissue. J Periodontol 81:917–925. https://doi.org/10.1902/jop.2010.090566
doi: 10.1902/jop.2010.090566
pubmed: 20450355
Zhang W, Zhou L, Dang J et al (2017) Human gingiva-derived mesenchymal stem cells ameliorate streptozoticin-induced T1DM in mice via suppression of T effector cells and up-regulating treg subsets. Sci Rep. https://doi.org/10.1038/s41598-017-14979-5
doi: 10.1038/s41598-017-14979-5
pubmed: 29273789
pmcid: 5741771
Zhang QZ, Nguyen AL, Yu WH, Le AD (2012) Human oral mucosa and gingiva: a unique reservoir for mesenchymal stem cells. J Dent Res 91:1011–1018. https://doi.org/10.1177/0022034512461016
doi: 10.1177/0022034512461016
pubmed: 22988012
pmcid: 3490281
Tomar GB, Srivastava RK, Gupta N et al (2010) Human gingiva-derived mesenchymal stem cells are superior to bone marrow-derived mesenchymal stem cells for cell therapy in regenerative medicine. Biochem Biophys Res Commun 393:377–383. https://doi.org/10.1016/j.bbrc.2010.01.126
doi: 10.1016/j.bbrc.2010.01.126
pubmed: 20138833
Diomede F, D’Aurora M, Gugliandolo A et al (2018) Biofunctionalized scaffold in bone tissue repair. Int J Mol Sci 19:1–17. https://doi.org/10.3390/ijms19041022
doi: 10.3390/ijms19041022
Mansour RN, Soleimanifar F, Abazari MF et al (2018) Collagen coated electrospun polyethersulfon nanofibers improved insulin producing cells differentiation potential of human induced pluripotent stem cells. Artif Cells Nanomed Biotechnol 46:S734–S739. https://doi.org/10.1080/21691401.2018.1508031
doi: 10.1080/21691401.2018.1508031
pubmed: 30284483
Li J, Xu SQ, Zhang K et al (2018) Treatment of gingival defects with gingival mesenchymal stem cells derived from human fetal gingival tissue in a rat model. Stem Cell Res Ther 9:1–8. https://doi.org/10.1186/s13287-017-0751-7
doi: 10.1186/s13287-017-0751-7
Pizzicannella J, Diomede F, Gugliandolo A et al (2019) 3D printing PLA/gingival stem cells/EVs upregulate miR-2861 and-210 during osteoangiogenesis commitment. Int J Mol Sci. https://doi.org/10.3390/ijms20133256
doi: 10.3390/ijms20133256
pubmed: 31801206
pmcid: 6929002
Zhang Q, Shi S, Liu Y et al (2010) Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J Immunol 184:1656–1656. https://doi.org/10.4049/jimmunol.0990118
doi: 10.4049/jimmunol.0990118
Sun W, Wang Z, Xu Q et al (2019) The treatment of systematically transplanted gingival mesenchymal stem cells in periodontitis in mice. Exp Ther Med. https://doi.org/10.3892/etm.2019.7165
doi: 10.3892/etm.2019.7165
pubmed: 32104295
pmcid: 7027318
Rafiee F, Pourteymourfard-tabrizi Z, Mehri-ghahfarrokhi A et al (2019) Differentiation of dental pulp stem cells into neuron-like cells. Int J Neurosci. https://doi.org/10.1080/00207454.2019.1664518
doi: 10.1080/00207454.2019.1664518
pubmed: 31599165
Loo ZX, Kunasekaran W, Govindasamy V et al (2014) Comparative analysis of cardiovascular development related genes in stem cells isolated from deciduous pulp and adipose tissue. Sci World J. https://doi.org/10.1155/2014/186508
doi: 10.1155/2014/186508
Couble ML, Farges JC, Bleicher F et al (2000) Odontoblast differentiation of human dental pulp cells in explant cultures. Calcif Tissue Int 66:129–138. https://doi.org/10.1007/PL00005833
doi: 10.1007/PL00005833
pubmed: 10652961
Samsonraj RM et al (2015) Establishing criteria for human mesenchymal stem cell potency. Transl Clin Res 33:1878–2189
Soltani A, Khazaei S, Mirtaghi SM et al (2021) Generation of high yield insulin-producing cells (IPCs) from various sources of stem cells, 1st edn. Elsevier Inc., Amsterdam, pp 235–268
Malekfar A, Valli KS, Kanafi MM, Bhonde RR (2016) Isolation and characterization of human dental pulp stem cells from cryopreserved pulp tissues obtained from teeth with irreversible pulpitis. J Endod 42:76–81. https://doi.org/10.1016/j.joen.2015.10.001
doi: 10.1016/j.joen.2015.10.001
pubmed: 26577871
Rao SR, Subbarayan R, Dinesh MG, Arumugam G (2016) Differentiation of human gingival mesenchymal stem cells into neuronal lineages in 3D bioconjugated injectable protein hydrogel construct for the management of neuronal disorder. Exp Mol Med 48:e209–e211. https://doi.org/10.1038/emm.2015.113
doi: 10.1038/emm.2015.113
pubmed: 26869025
pmcid: 4892868
Mathew SA, Naik C, Cahill PA, Bhonde RR (2019) Placental mesenchymal stromal cells as an alternative tool for therapeutic angiogenesis. Cell Mol Life Sci. https://doi.org/10.1007/s00018-019-03268-1
doi: 10.1007/s00018-019-03268-1
pubmed: 31468060
Kadam S, GovindasamyBhonde VR (2012) Generation of functional islets from human umbilical cord and placenta derived mesenchymal stem cells. In: Singh SR (ed) Methods in molecular biology. Humana Press, Totowa, pp 291–313
Enderami SE, Soleimani M, Mortazavi Y et al (2018) Generation of insulin-producing cells from human adipose-derived mesenchymal stem cells on PVA scaffold by optimized differentiation protocol. J Cell Physiol 233:4327–4337. https://doi.org/10.1002/jcp.26266
doi: 10.1002/jcp.26266
pubmed: 29150935
Gopurappilly R, Bhat V, Bhonde R (2013) Pancreatic tissue resident mesenchymal stromal cell (MSC)-like cells as a source of in vitro islet neogenesis. J Cell Biochem 114:2240–2247. https://doi.org/10.1002/jcb.24572
doi: 10.1002/jcb.24572
pubmed: 23606308
Egan JM, Bulotta A, Hui H, Perfetti R (2003) GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells. Diabetes Metab Res Rev 19:115–123. https://doi.org/10.1002/dmrr.357
doi: 10.1002/dmrr.357
pubmed: 12673779
Mitutsova V, Yeo WWY, Davaze R et al (2017) Adult muscle-derived stem cells engraft and differentiate into insulin-expressing cells in pancreatic islets of diabetic mice. Stem Cell Res Ther 8:1–14. https://doi.org/10.1186/s13287-017-0539-9
doi: 10.1186/s13287-017-0539-9
Navarro-Tableros V, Gai C, Gomez Y et al (2019) Islet-like structures generated in vitro from adult human liver stem cells revert hyperglycemia in diabetic scid mice. Stem Cell Rev Rep 15:93–111. https://doi.org/10.1007/s12015-018-9845-6
doi: 10.1007/s12015-018-9845-6
pubmed: 30191384